Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Congenital Abnormalities × Epirubicin × Clear all

Sponsor

Conditions

Breast Neoplasms 22 Stomach Neoplasms 6 Esophageal Neoplasms 5 Inflammatory Breast Neoplasms 4 Triple Negative Breast Neoplasms 2 Adenocarcinoma Of Esophagus 2 Sarcoma 1 Neoplasms 1 Her2-Positive Breast Cancer 1 Esophageal Squamous Cell Carcinoma 1 Breast Neoplasms, Male 1 Adenocarcinoma 1

Interventions

fludarabine phosphate 32 Cytarabine 29 Cyclophosphamide 24 Whole-Body Irradiation 23 Peripheral Blood Stem Cell Transplantation 23 Mycophenolic Acid 22 Busulfan 21 Tacrolimus 19 Cyclosporine 15 Filgrastim 14 Etoposide 14 Antilymphocyte Serum 14 Methotrexate 13 Melphalan 11 Idarubicin 9 Granulocyte Colony-Stimulating Factor 9 Clofarabine 8 Mitoxantrone 7 Flow Cytometry 7 Sirolimus 6 Radiotherapy 6 Cord Blood Stem Cell Transplantation 6 aldesleukin 5 Vorinostat 5 Daunorubicin 5 thymoglobulin 4 fludarabine 4 alvocidib 4 Thiotepa 4 Polymerase Chain Reaction 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡